Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 78,229 | 58,590 | 82,763 | 131,954 | 67,329 |
| Marketable Securities | 426,181 | 517,859 | 573,605 | 461,976 | 562,108 |
| TOTAL | $507,956 | $583,026 | $666,640 | $605,218 | $636,100 |
| Non-Current Assets | |||||
| PPE Net | 100,938 | 88,034 | 80,120 | 72,750 | 59,159 |
| Investments And Advances | 91,588 | 78,247 | 46,288 | 10,227 | 0 |
| Other Non-Current Assets | 76,851 | 79,518 | 59,742 | 62,378 | 73,199 |
| TOTAL | $269,377 | $245,799 | $186,150 | $145,355 | $132,358 |
| Total Assets | $777,333 | $828,825 | $852,790 | $750,573 | $768,458 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 27,377 | 12,181 | 21,914 | 13,369 | 13,513 |
| Accrued Expenses | 56,766 | 45,969 | 34,192 | 35,774 | 35,074 |
| TOTAL | $89,200 | $64,766 | $60,534 | $55,059 | $54,871 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,000 | 1,000 | 1,000 | 1,000 | N/A |
| Other Non-Current Liabilities | 65,474 | 64,729 | 46,843 | 47,083 | 57,089 |
| TOTAL | $66,474 | $65,729 | $47,843 | $48,083 | $57,089 |
| Total Liabilities | $155,674 | $130,495 | $108,377 | $103,142 | $111,960 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 157,168 | 156,899 | 155,032 | 152,849 | 146,979 |
| Common Shares | 7 | 7 | 7 | 6 | 6 |
| Retained earnings | -1,172,445 | -1,073,115 | -986,993 | -905,642 | -830,193 |
| Other shareholders' equity | -601 | -5 | 33 | 96 | 19 |
| TOTAL | $621,659 | $698,330 | $744,413 | $647,431 | $656,498 |
| Total Liabilities And Equity | $777,333 | $828,825 | $852,790 | $750,573 | $768,458 |